Heart Test Laboratories Operating Income

Heart Test Laboratories posts a operating income of $-1.9B as of January 2026. That compares with $-6.4B in the prior-year period — up 70.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Heart Test Laboratories's operating income was $-6.4B. The latest reading is $-1.9B — a 70.8% year-over-year increase (period ending January 2026). Use the history and growth charts on this page for a longer lookback.

Operating Income is one piece of Heart Test Laboratories's financial statement story. At $-1.9B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for HSCS's operating income usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Heart Test Laboratories's other metric pages and overview cover the third.